Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shayne Andrew

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Immunology|November 3, 2011
Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitisAbigail C Buenafe, Shayne Andrew, Halina Offner, et al.
Immunology|January 12, 2010
Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cellsAbigail C Buenafe, Shayne Andrew, Michael Afentoulis, et al.
Microvascular Research|September 3, 2002
Cultivation and characterization of coronary microvascular endothelial cells: a novel porcine model using micropigsEdward K Johnson, Margaret E Schelling, Ian J Quitadamo, et al.
Investigative Ophthalmology & Visual Science|December 15, 2011
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 miceGrazyna Adamus, Lori Brown, Shayne Andrew, et al.
European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetesSarah L Kerns, Jaime Guevara-Aguirre, Shayne Andrew, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Immunology|November 3, 2011
Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitisAbigail C Buenafe, Shayne Andrew, Halina Offner, et al.
Immunology|January 12, 2010
Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cellsAbigail C Buenafe, Shayne Andrew, Michael Afentoulis, et al.
Microvascular Research|September 3, 2002
Cultivation and characterization of coronary microvascular endothelial cells: a novel porcine model using micropigsEdward K Johnson, Margaret E Schelling, Ian J Quitadamo, et al.
Investigative Ophthalmology & Visual Science|December 15, 2011
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 miceGrazyna Adamus, Lori Brown, Shayne Andrew, et al.
European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetesSarah L Kerns, Jaime Guevara-Aguirre, Shayne Andrew, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Pageof 1